Atelvia (uh-TEL-vee-uh), a new delayed-release form of risedronate (Actonel), for postmenopausal osteoporosis
You'll see Atelvia (uh-TEL-vee-uh), a new delayed-release form of risedronate (Actonel), for postmenopausal osteoporosis.
Atelvia will be promoted as more convenient because it's taken AFTER breakfast...instead of 30 to 60 minutes BEFORE breakfast like the other oral bisphosphonates.
Atelvia is designed to reduce interference with calcium, iron, and other cations that decrease bisphosphonate absorption.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote